Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database

BACKGROUND: Immune checkpoint inhibitors (ICIs) have elicited durable antitumor responses in multiple types of cancers. However, ICIs could also induce potential toxicities that involve all organs, including renal system. In this study, we aimed to conduct a comprehensive description of the ICIs‐ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Fangyuan, Zhai, Yinghong, Yuan, Lei, Liang, Jizhou, Xu, Jinfang, Guo, Xiaojing, Zhou, Xiang, Lin, Zhen, Sun, Jinhai, Ye, Xiaofei, He, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683558/
https://www.ncbi.nlm.nih.gov/pubmed/34845857
http://dx.doi.org/10.1002/cam4.4343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683558/
https://www.ncbi.nlm.nih.gov/pubmed/34845857
http://dx.doi.org/10.1002/cam4.4343

Ejemplares similares